LENVALIEVA 4mg Capsule (Lenvatinib)

LENVALIEVA 4mg Capsules contain Lenvatinib, a multi-targeted tyrosine kinase inhibitor used in the treatment of certain types of cancer. It works by blocking proteins involved in tumor growth and the formation of new blood vessels that supply tumors.

Key Information

• Active Ingredient: Lenvatinib
• Strength: 4mg
• Manufacturer: Allieva Pharma
• Uses: Used for certain cases of differentiated thyroid cancer, liver cancer, kidney cancer and endometrial cancer.
• Administration: Taken orally as directed by a healthcare professional. Capsules should generally be swallowed whole.
• Common Side Effects: Fatigue, high blood pressure, diarrhea, nausea, vomiting, joint or muscle pain, decreased appetite and weight loss may occur.
• Important: Blood pressure, liver function and thyroid function may require regular monitoring during treatment.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.